Despite the availability of effective medications for the management of atopic dermatitis and xerosis, patients may use nonconventional therapies such as topical oils.
In a recent systematic review of the literature on steroid phobia, Li and colleagues proposed that aversion to the use of topical corticosteroids arises from misinformation rather than from an irrational fear. 7 Skin-thinning and effects on growth and development are cited as the most common concerns of the parents of children using topical corticosteroids. 7 Despite the large number of patients choosing CAM, few studies have investigated the use of these products in individuals with AD or xerosis. One study found that health professionals in maternity units and neonatal intensive care units in the United Kingdom often use olive oil as a skin emollient and anecdotally recommend its use. 8 In our practice, patients have frequently reported the use of coconut oil. We chose to examine the literature on the tolerability and effects of these oils for the treatment of xerosis and AD in children. We also reviewed the literature regarding the use of sunflower seed oil (SSO) as a potential alternative to coconut and olive oil, because it has been reported to be a promising complementary medicine for AD. 9 We searched "coconut oil," each in combination with "atopic dermatitis," "xerosis," and "topical," and included all relevant articles written in English.
Studies often use transepidermal water loss (TEWL) as an objective measure of skin barrier function. TEWL is defined as the rate at which water vapor is lost from the body through the skin. High TEWL suggests a defective skin barrier. TEWL after tape stripping, which removes superficial corneocytes from the epidermis, measures the maintenance of skin barrier function after minor epidermal injury. 10 Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy, which is another objective measure of skin barrier, assesses the organization of the lipid lamellae in the epidermis, which is a determinant of stratum corneum permeability. 
| OLIVE OIL
Olive oil is a form of liquid fat obtained by pressing olives. The use of olive oil for skin care dates back to ancient Egypt. 12 Olive oil can be defined according to its ratio of fatty acids (palmitic acid, oleic acid, linoleic acid, linolenic acid), with oleic acid being the predominant component. 13, 14 Although the use of olive oil is popular in the United Kingdom, 8 only a small number of studies have investigated its efficacy as an emollient.
In a pilot study, Cooke and colleagues randomized 115 neonates to three treatment groups-no oil, four drops of olive oil, four drops of SSO-applied twice daily to the left side of the body for 4 weeks (Table 1) . No differences were observed in TEWL between the olive oil and no-oil groups, but the olive oiltreated group had a significantly lower ordering of lipids in the stratum corneum than the no-oil group as measured using ATR-FTIR. 13 A lower ordering of lipids suggests abnormal lamellar lipid development and is associated with poorer skin barrier function. 13 In an earlier study of seven adults who applied olive oil twice daily to the left forearm, TEWL after tape stripping was significantly greater in the treated forearm than the untreated forearm. 14 Together these two studies suggest impairment of the skin barrier after topical application of olive oil. One larger study compared the cutaneous effects of an olive oil mixture with those of a water-in-oil emollient cream or no treatment in 173 neonates.
The authors demonstrated a statistically significantly more beneficial effect of the olive oil than no treatment based on a 4-point skin condition grading scale. Because an olive oil mixture containing 30% olive oil and 70% lanolin was used, the results are difficult to attribute directly to the olive oil itself. 15 Although there is mixed clinical evidence of the benefits of olive oil as an emollient, laboratory studies suggest that it may be harmful to the skin. The negative effects of olive oil are attributed to its main constituent, oleic acid, which has been shown to increase skin penetration by decreasing the conformational order of the lipids of the stratum corneum and inducing lipid phase separation. 16 Oleic acid may also induce inflammation through an N-methyl-D-aspartic acid (NMDA)-type receptor in keratinocytes. Molecular inhibitors of NMDA receptors have been shown to reduce TEWL caused by the application of oleic acid on the skin of mice. 17 In terms of antimicrobial activity, in vitro studies demonstrate that olive oil and oleic acid have little to no antibacterial effect, 18, 19 although there is evidence that olive oil, specifically hydroxytyrosol, which is an antioxidant found in olive oil, may have antifungal activity. 20, 21 Still, its use for certain cutaneous diseases such as seborrheic dermatitis should be approached with caution because olive oil is used as a standard in vitro culture medium for Malassezia species. 22 Olive oil contains saturated and unsaturated fatty acids, which may stimulate growth of Malassezia and induce inflammation, respectively.
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It is also important to consider the risk of allergic contact dermatitis (ACD) in the context of AD. 24 On rare occasions, olive oil has been reported to cause irritant contact dermatitis and ACD. 25, 26 Given the potential occurrence of contact dermatitis and its adverse effects on the skin barrier, olive oil may exacerbate rather than alleviate xerosis and AD.
| COCONUT OIL
Coconut oil is derived from the meat, the white lining within the shell, of mature coconuts. In recent years, coconut oil has become increasingly popular in food and skin products. 27 Coconut oil contains high levels of lauric acid, which has been shown to have antimicrobial and anti-inflammatory effects in vitro and in vivo in mice. 19, 28, 29 Similar to olive oil, coconut oil is defined according to its ratio of fatty acids; lauric acid is the highest in concentration, followed by myristic acid. 30 Few studies have investigated the efficacy of coconut oil in the treatment of AD and xerosis. [31] [32] [33] [34] All studies used virgin coconut oil, which is defined as coconut oil processed within 24 hours of harvest to avoid the formation of fatty acids that may cause skin irritation. 34, 35 Coconut oil has been shown to have beneficial effects on the skin barrier in neonates and adults. 31, 32 Seventy-four preterm infants were randomized to twice-daily application of coconut oil during the first 7 days of life or no treatment. The coconut oil-treated group had near 50% less TEWL than the infants who received no treatment, which supports the efficacy of coconut oil as an emollient. 32 In another study investigating the treatment of xerosis, 34 adults were randomized to apply coconut oil or mineral oil to their legs twice daily. No differences were seen in TEWL or in clinical measures between the two groups, suggesting that coconut oil is at least as effective as mineral oil when used for the treatment of xerosis. 31 Evangelista and colleagues investigated the use of coconut oil specifically in the context of AD, with favorable results; 33 117 children with mild to moderate AD were randomized to apply coconut oil or mineral oil twice daily to all body surfaces for 8 weeks. The authors found statistically significantly lower TEWL and in Scoring Atopic Dermatitis (SCORAD) index in the coconut oil group than the mineral oil group, supporting its efficacy. 33 In a similar study of 52 adults with moderate AD randomized to apply coconut oil or olive 42 Assess effect of SSO-containing emollient on use of topical steroid in treatment of atopic dermatitis Randomized controlled trial 86 children 3-wk treatment: 5 groups receiving topical application of desonide 0.05% (range: one application every other day to twice daily) combined or not with emollient containing 2% SSO As assessed using SCORAD, every-otherday application of corticosteroid combined with SSO-containing emollient had similar outcome to once-and twicedaily application of corticosteroid with emollient SCORAD, SCORing Atopic Dermatitis; SSO, sunflower seed oil; TEWL, transepidermal water loss.
oil to affected areas twice daily for 4 weeks, Verallo-Rowell found statistically significant lower Staphylococcus aureus colonization and significantly lower SCORAD indexes in the coconut oil than the olive oil group. 34 These findings suggest that the antimicrobial properties of coconut oil may account for the observed positive effects on AD.
Although coconut oil derivatives such as cocamidopropyl betaine 30 and cocamide diethanolamine (DEA) 36 have been reported to cause ACD, there have been no reports of the constituents of unaltered coconut oil causing ACD. In a study examining the allergenicity and cross-reactivity of coconut oil derivatives, none of the participants had positive patch tests results to coconut oil or lauric acid. 37 Together, the results of these trials and lack of reports of ACD to coconut oil suggest that coconut oil is a potentially beneficial complementary treatment for xerosis and AD.
| SUNFLOWER SEED OIL
Of the three oils discussed in this article, SSO has been most extensively investigated in the treatment of xerosis and AD. 13, [38] [39] [40] [41] [42] [43] As with other oils, SSO is defined according to the ratios of its fatty acid components: linoleic acid constitutes approximately 60% of the oil, which also contains oleic acid, palmitic acid, stearic acid, and linolenic acid. 9 Linoleic acid has been shown to be a necessary fatty acid to maintain normal barrier function of the epidermis. 44 Cutaneous inflammation is modulated through the conversion of linoleic acid to arachidonic acid, a precursor to prostaglandin E2. 45 In infants with linoleic acid deficiency, application of topical linoleic acid restored the skin barrier as assessed by resolution of prior dermatitis. 46 It has therefore been hypothesized that topical application of linoleic acid, contained within SSO, can improve skin barrier function and decrease inflammation. 9 The purported anti-inflammatory and barrier-improving effects of SSO may contribute to lower mortality in preterm infants according to a randomized controlled trial performed in Bangladesh; 38 497 infants born at less than 33 weeks gestation were randomized to no treatment or treatment with petrolatum ointment or high-linoleate SSO applied three times daily for 2 weeks and then two times daily until discharge. 38 Preterm infants treated with petrolatum ointment or SSO, which is a rich source of essential fatty acids, were less likely to develop nosocomial infections and had lower mortality than untreated controls. 38, 39, 47 Two other studies examining SSO for treatment of xerosis had more equivocal results. In Cooke and colleagues, as described above, no differences in TEWL or erythema or skin scores were seen between the neonatal group treated with SSO twice daily for 4 weeks and the untreated control group. 13 In another prospective randomized trial of 22 preterm infants treated with SSO daily or not treated, Kanti and colleagues found statistically significant higher TEWL than in controls, suggesting disruption of the skin barrier, although the authors noted that all TEWL scores remained within the range of values previously described in healthy preterm and full-term infants after birth and that their cohort was too small to draw conclusions regarding SSO treatment for premature infants. 41 For the treatment of AD specifically, Msika and colleagues demonstrated that SSO could potentially be used as a steroid-sparing agent. Eighty-six children with moderate AD were randomized to receive daily topical corticosteroids or every other day corticosteroids alternating with emollient containing 2% SSO. 42 All groups had similar reductions in SCORAD. The group treated with SSO alternating with corticosteroid had significantly greater improvement in lichenification than the corticosteroid alone group. 42 Two other studies in patients with a history of AD found no adverse effects of daily SSO use. 14, 43 In addition, to our knowledge, SSO has not been reported to cause contact dermatitis.
| CONCLUSION
Practitioners should be familiar with the literature regarding olive oil, SSO, and coconut oil to be able to appropriately address parental preferences for "all natural" products. Although no oil can be recom- 
